RLYB (Rallybio Corporation Common Stock) Stock Analysis - Community
Rallybio Corporation Common Stock (RLYB) is a publicly traded Healthcare sector company. As of May 21, 2026, RLYB trades at $14.43 with a market cap of $74.70M and a P/E ratio of -5.06. RLYB moved +2.18% today. Year to date, RLYB is +168.41%; over the trailing twelve months it is +427.04%. Its 52-week range spans $1.76 to $15.31. Rallies surfaces RLYB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
How does the Rallies community trade RLYB?
Rallies community data for RLYB shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
ADAR1 Capital Management, LLC bought 10.00K (~$139.82K) on May 19, 2026.
ADAR1 Capital Management, LLC bought 200 (~$2.76K) on May 19, 2026.
ADAR1 Capital Management, LLC bought 6.01K (~$83.98K) on May 18, 2026.
RLYB Analyst Consensus
RLYB analyst coverage data. Average price target: $0.00.
Common questions about RLYB
How does the Rallies community trade RLYB?
Rallies community data for RLYB shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
Does Rallies show retail investor data for RLYB?
Rallies shows anonymized community ownership, retail positioning, sentiment, and portfolio context for RLYB when enough community data is available.
Is RLYB research on Rallies investment advice?
No. Rallies provides research, data, and educational context for RLYB. It does not provide personalized investment advice.